RTS,S vaccination is associated with serologic evidence of decreased exposure to plasmodium falciparum liver-and blood-stage parasites

Molecular and Cellular Proteomics

Volumn 14, Issue 3, 2015, Pages 519-531

  Campo, Joe J ^a,b,e   Aponte, John J ^a,b   Skinner, Jeff ^c   Nakajima, Rie ^d   Molina, Douglas M ^e   Liang, Li ^d   Sacarlal, Jahit ^a,f   Alonso, Pedro L ^a,b   Crompton, Peter D ^c   Felgner, Philip L ^d,e   Dobaño, Carlota ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Ministério de Saúde   (Mozambique)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Antigen Discovery Inc   (United States)

^f EDUARDO MONDLANE UNIVERSITY   (Mozambique)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CIRCUMSPOROZOITE PROTEIN; IMMUNOGLOBULIN G ANTIBODY; MALARIA VACCINE; RTS,S VACCINE; UNCLASSIFIED DRUG; PARASITE ANTIGEN;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BLOOD; CASE CONTROL STUDY; CELL INVASION; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEBRILE MALARIA; FEMALE; FOLLOW UP; HUMAN; LIFE CYCLE STAGE; LIVER; LIVER CELL; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; MOZAMBICAN; PARASITE; PARASITEMIA; PHASE 2 CLINICAL TRIAL; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN MICROARRAY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; SPOROZOITE; VACCINATION; CLINICAL TRIAL; DRUG EFFECTS; IMMUNOLOGY; INFANT; MOZAMBIQUE; PARASITOLOGY; PHYSIOLOGY;

PLASMODIUM FALCIPARUM;

ANTIGENS, PROTOZOAN; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; HUMANS; INFANT; LIVER; MALARIA VACCINES; MALARIA, FALCIPARUM; MOZAMBIQUE; PLASMODIUM FALCIPARUM; PROTEIN ARRAY ANALYSIS; SPOROZOITES;

EID: 84924341877     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.044677     Document Type: Article

References (44)

1. Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Milman, J., Mandomando, I., Spiessens, B., Guinovart, C., Espasa, M., Bassat, Q., Aide, P., Ofori-Anyinam, O., Navia, M. M., Corachan, S., Ceuppens, M., Dubois, M. C., Demoitié , M. A., Dubovsky, F., Mené ndez, C., Tornieporth, N., Ballou, W. R., Thompson, R., and Cohen, J. (2004) Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364, 1411-1420
2. Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Lang, T., Gould, J., Dubois, M.-C., Demoitié , M.-A., Stallaert, J.-F., Vansadia, P., Carter, T., Njuguna, P., Awuondo, K. O., Malabeja, A., Abdul, O., Gesase, S., Mturi, N., Drakeley, C. J., Savarese, B., Villafana, T., Ballou, W. R., Cohen, J., Riley, E. M., Lemnge, M. M., Marsh, K., and von Seidlein, L. (2008) Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N. Engl. J. Med. 359, 2521-2532
3. Abdulla, S., Oberholzer, R., Juma, O., Kubhoja, S., Machera, F., Membi, C., Omari, S., Urassa, A., Mshinda, H., Jumanne, A., Salim, N., Shomari, M., Aebi, T., Schellenberg, D. M., Carter, T., Villafana, T., Demoitié , M.-A., Dubois, M.-C., Leach, A., Lievens, M., Vekemans, J., Cohen, J., Ballou, W. R., and Tanner, M. (2008) Safety and immunogenicity of RTS,S/ AS02D malaria vaccine in infants. N. Engl. J. Med. 359, 2533-2544
4. Agnandji, S. T., Lell, B., Soulanoudjingar, S. S., Fernandes, J. F., Abossolo, B. P., Conzelmann, C., Methogo, B. G., Doucka, Y., Flamen, A., Mordmüller, B., Issifou, S., Kremsner, P. G., Sacarlal, J., Aide, P., Lanaspa, M., Aponte, J. J., Nhamuave, A., Quelhas, D., Bassat, Q., Mandjate, S., Macete, E., Alonso, P., Abdulla, S., Salim, N., Juma, O., Shomari, M., Shubis, K., Machera, F., Hamad, A. S., Minja, R., Mtoro, A., Sykes, A., Ahmed, S., Urassa, A. M., Ali, A. M., Mwangoka, G., Tanner, M., Tinto, H., D'Alessandro, U., Sorgho, H., Valea, I., Tahita, M. C., Kaboré , W., Oué draogo, S., Sandrine, Y., Guiguemdé , R. T., Oué draogo, J. B., Hamel, M. J., Kariuki, S., Odero, C., Oneko, M., Otieno, K., Awino, N., Omoto, J., Williamson, J., Muturi-Kioi, V., Laserson, K. F., Slutsker, L., Otieno, W., Otieno, L., Nekoye, O., Gondi, S., Otieno, A., Ogutu, B., Wasuna, R., Owira, V., Jones, D., Onyango, A. A., Njuguna, P., Chilengi, R., Akoo, P., Kerubo, C., Gitaka, J., Maingi, C., Lang, T., Olotu, A., Tsofa, B., Bejon, P., Peshu, N., Marsh, K., Owusu-Agyei, S., Asante, K. P., Osei-Kwakye, K., Boahen, O., Ayamba, S., Kayan, K., Owusu-Ofori, R., Dosoo, D., Asante, I., Adjei, G., Chandramohan, D., Greenwood, B., Lusingu, J., Gesase, S., Malabeja, A., Abdul, O., Kilavo, H., Mahende, C., Liheluka, E., Lemnge, M., Theander, T., Drakeley, C., Ansong, D., Agbenyega, T., Adjei, S., Boateng, H. O., Rettig, T., Bawa, J., Sylverken, J., Sambian, D., Agyekum, A., Owusu, L., Martinson, F., Hoffman, I., Mvalo, T., Kamthunzi, P., Nkomo, R., Msika, A., Jumbe, A., Chome, N., Nyakuipa, D., Chintedza, J., Ballou, W. R., Bruls, M., Cohen, J., Guerra, Y., Jongert, E., Lapierre, D., Leach, A., Lievens, M., Ofori-Anyinam, O., Vekemans, J., Carter, T., Leboulleux, D., Loucq, C., Radford, A., Savarese, B., Schellenberg, D., Sillman, M., and Vansadia, P. (2011) First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N. Engl. J. Med. 365, 1863-1875
5. Agnandji, S. T., Lell, B., Fernandes, J. F., Abossolo, B. P., Methogo, B. G. N. O., Kabwende, A. L., Adegnika, A. A., Mordmüller, B., Issifou, S., Kremsner, P. G., Sacarlal, J., Aide, P., Lanaspa, M., Aponte, J. J., Machevo, S., Acacio, S., Bulo, H., Sigauque, B., Macete, E., Alonso, P., Abdulla, S., Salim, N., Minja, R., Mpina, M., Ahmed, S., Ali, A. M., Mtoro, A. T., Hamad, A. S., Mutani, P., Tanner, M., Tinto, H., D'Alessandro, U., Sorgho, H., Valea, I., Bihoun, B., Guiraud, I., Kaboré , B., Sombié , O., Guiguemdé , R. T., Oué draogo, J. B., Hamel, M. J., Kariuki, S., Oneko, M., Odero, C., Otieno, K., Awino, N., McMorrow, M., Muturi-Kioi, V., Laserson, K. F., Slutsker, L., Otieno, W., Otieno, L., Otsyula, N., Gondi, S., Otieno, A., Owira, V., Oguk, E., Odongo, G., Woods, J. B., Ogutu, B., Njuguna, P., Chilengi, R., Akoo, P., Kerubo, C., Maingi, C., Lang, T., Olotu, A., Bejon, P., Marsh, K., Mwambingu, G., Owusu-Agyei, S., Asante, K. P., Osei-Kwakye, K., Boahen, O., Dosoo, D., Asante, I., Adjei, G., Kwara, E., Chandramohan, D., Greenwood, B., Lusingu, J., Gesase, S., Malabeja, A., Abdul, O., Mahende, C., Liheluka, E., Malle, L., Lemnge, M., Theander, T. G., Drakeley, C., Ansong, D., Agbenyega, T., Adjei, S., Boateng, H. O., Rettig, T., Bawa, J., Sylverken, J., Sambian, D., Sarfo, A., Agyekum, A., Martinson, F., Hoffman, I., Mvalo, T., Kamthunzi, P., Nkomo, R., Tembo, T., Tegha, G., Tsidya, M., Kilembe, J., Chawinga, C., Ballou, W. R., Cohen, J., Guerra, Y., Jongert, E., Lapierre, D., Leach, A., Lievens, M., Ofori-Anyinam, O., Olivier, A., Vekemans, J., Carter, T., Kaslow, D., Leboulleux, D., Loucq, C., Radford, A., Savarese, B., Schellenberg, D., Sillman, M., and Vansadia, P. (2012) A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N. Engl. J. Med. 367, 2284-2295
6. Regules, J. A., Cummings, J. F., and Ockenhouse, C. F. (2011) The RTS,S vaccine candidate for malaria. Expert Rev. Vaccines 10, 589-599
7. Moorthy, V. S., and Ballou, W. R. (2009) Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data. Malar. J. 8, 312
8. Guinovart, C., Aponte, J. J., Sacarlal, J., Aide, P., Leach, A., Bassat, Q., Macete, E., Dobañ o, C., Lievens, M., Loucq, C., Ballou, W. R., Cohen, J., and Alonso, P. L. (2009) Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children. PLoS One 4, e5165
9. Campo, J. J., Dobañ o, C., Sacarlal, J., Guinovart, C., Mayor, A., Angov, E., Dutta, S., Chitnis, C., Macete, E., Aponte, J. J., and Alonso, P. L. (2011) Impact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigens. PLoS One 6, e25779
10. Sutherland, C. J., Drakeley, C. J., and Schellenberg, D. (2007) How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions? Malar. J. 6, 161
11. Doolan, D. L. (2011) Plasmodium immunomics. Int. J. Parasitol. 41, 3-20
12. Templin, M. F., Stoll, D., Schwenk, J. M., Pötz, O., Kramer, S., and Joos, T. O. (2003) Protein microarrays: promising tools for proteomic research. Proteomics 3, 2155-2166
13. Hudgens, M. G., Gilbert, P. B., and Self, S. G. (2004) Endpoints in vaccine trials. Stat. Methods Med. Res. 13, 89-114
14. Pulendran, B., Li, S., and Nakaya, H. I. (2010) Systems vaccinology. Immunity 33, 516-529
15. Tran, T. M., Samal, B., Kirkness, E., and Crompton, P. D. (2012) Systems immunology of human malaria. Trends Parasitol. 28, 248-257
16. Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Aide, P., Sigauque, B., Milman, J., Mandomando, I., Bassat, Q., Guinovart, C., Espasa, M., Corachan, S., Lievens, M., Navia, M. M., Dubois, M. C., Menendez, C., Dubovsky, F., Cohen, J., Thompson, R., and Ballou, W. R. (2005) Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 366, 2012-2018
17. Davies, D. H., Liang, X., Hernandez, J. E., Randall, A., Hirst, S., Mu, Y., Romero, K. M., Nguyen, T. T., Kalantari-Dehaghi, M., Crotty, S., Baldi, P., Villarreal, L. P., and Felgner, P. L. (2005) Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl. Acad. Sci. U.S.A. 102, 547-552
18. Crompton, P. D., Kayala, M. A., Traore, B., Kayentao, K., Ongoiba, A., Weiss, G. E., Molina, D. M., Burk, C. R., Waisberg, M., Jasinskas, A., Tan, X., Doumbo, S., Doumtabe, D., Kone, Y., Narum, D. L., Liang, X., Doumbo, O. K., Miller, L. H., Doolan, D. L., Baldi, P., Felgner, P. L., and Pierce, S. K. (2010) A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc. Natl. Acad. Sci. U.S.A. 107, 6958-6963
19. Trieu, A., Kayala, M. A., Burk, C., Molina, D. M., Freilich, D. A., Richie, T. L., Baldi, P., Felgner, P. L., and Doolan, D. L. (2011) Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol. Cell Proteomics 10, M111.007948
20. Sundaresh, S., Doolan, D. L., Hirst, S., Mu, Y., Unal, B., Davies, D. H., Felgner, P. L., and Baldi, P. (2006) Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics 22, 1760-1766
21. Sboner, A., Karpikov, A., Chen, G., Smith, M., Mattoon, D., Dawn, M., Freeman-Cook, L., Schweitzer, B., and Gerstein, M. B. (2009) Robustlinear-model normalization to reduce technical variability in functional protein microarrays. J. Proteome Res. 8, 5451-5464
22. R Development Core Team (2013) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
23. Ritchie, M. E., Silver, J., Oshlack, A., Holmes, M., Diyagama, D., Holloway, A., and Smyth, G. K. (2007) A comparison of background correction methods for two-colour microarrays. Bioinformatics 23, 2700-2707
24. Smyth, G. K. (2005) Bioinformatics and computational biology solutions using R and Bioconductor, Statistics for Biology and Health., eds. Gentleman, R., Carey, V., Huber, W., Irizarry, R., and Dudoit, S. (Springer New York), 397-420
25. Huber, W., von Heydebreck, A., Sultmann, H., Poustka, A., and Vingron, M. (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 Suppl 1, S96-S104
26. Bolstad, B. M., Irizarry, R. A., Astrand, M., and Speed, T. P. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193
27. The Plasmodium Genome Database Collaborative (2001) PlasmoDB: An integrative database of the Plasmodium falciparum genome. Nucleic Acids Res. 29, 66-69
28. Florens, L., Washburn, M. P., Raine, J. D., Anthony, R. M., Grainger, M., Haynes, J. D., Moch, J. K., Muster, N., Sacci, J. B., Tabb, D. L., Witney, A. A., Wolters, D., Wu, Y., Gardner, M. J., Holder, A. A., Sinden, R. E., Yates, J. R., and Carucci, D. J. (2002) A proteomic view of the Plasmodium falciparum life cycle. Nature 419, 520-526
29. Smyth, G. K. (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, 1-69
30. Benjamini, Y., and Yosef, H. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57, 289-300
31. Campo, J. J., Sacarlal, J., Aponte, J. J., Aide, P., Nhabomba, A. J., Dobañ o, C., and Alonso, P. L. (2014) Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique. Vaccine 32, 2209-2216
32. Steere, A. C., Sikand, V. K., Meurice, F., Parenti, D. L., Fikrig, E., Schoen, R. T., Nowakowski, J., Schmid, C. H., Laukamp, S., Buscarino, C., and Krause, D. S. (1998) Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N. Engl. J. Med. 339, 209-15
33. Cohen, S., McGregor, I. A., and Carrington, S. (1961) Gamma-globulin and acquired immunity to human malaria. Nature 192, 733-737
34. Bouharoun-Tayoun, H., Attanath, P., Sabchareon, A., Chongsuphajaisiddhi, T., and Druilhe, P. (1990) Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172, 1633-1641
35. Quelhas, D., Puyol, L., Quintó , L., Serra-Casas, E., Nhampossa, T., Macete, E., Aide, P., Mayor, A., Mandomando, I., Sanz, S., Aponte, J. J., Chauhan, V. S., Chitnis, C. E., Alonso, P. L., Mené ndez, C., and Dobañ o, C. (2008) Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique. Clin. Vaccine Immunol. 15, 1282-1291
36. Aponte, J. J., Menendez, C., Schellenberg, D., Kahigwa, E., Mshinda, H., Vountasou, P., Tanner, M., and Alonso, P. L. (2007) Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation. PLoS Med. 4, e242
37. Greenhouse, B., Ho, B., Hubbard, A., Njama-Meya, D., Narum, D. L., Lanar, D. E., Dutta, S., Rosenthal, P. J., Dorsey, G., and John, C. C. (2011) Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J. Infect. Dis. 204, 19-26
38. Bejon, P., Cook, J., Bergmann-Leitner, E., Olotu, A., Lusingu, J., Mwacharo, J., Vekemans, J., Njuguna, P., Leach, A., Lievens, M., Dutta, S., von Seidlein, L., Savarese, B., Villafana, T., Lemnge, M. M., Cohen, J., Marsh, K., Corran, P. H., Angov, E., Riley, E. M., and Drakeley, C. J. (2011) Effect of the Pre-erythrocytic candidate malaria vaccine RTS,S/ AS01E on blood stage immunity in young children. J. Infect. Dis. 204, 9-18
39. Hviid, L. (2005) Naturally acquired immunity to Plasmodium falciparum malaria in Africa. Acta Trop. 95, 270-275
40. Bejon, P., Warimwe, G., Mackintosh, C. L., Mackinnon, M. J., Kinyanjui, S. M., Musyoki, J. N., Bull, P. C., and Marsh, K. (2009) Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure. Infect. Immun. 77, 1917-1923
41. Doolan, D. L., Mu, Y., Unal, B., Sundaresh, S., Hirst, S., Valdez, C., Randall, A., Molina, D., Liang, X., Freilich, D. A., Oloo, J. A., Blair, P. L., Aguiar, J. C., Baldi, P., Davies, D. H., and Felgner, P. L. (2008) Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 8, 4680-4694
42. Barry, A. E., Trieu, A., Fowkes, F. J. I., Pablo, J., Kalantari-Dehaghi, M., Jasinskas, A., Tan, X., Kayala, M. A., Tavul, L., Siba, P. M., Day, K. P., Baldi, P., Felgner, P. L., and Doolan, D. L. (2011) The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic area. Mol. Cell Proteomics 10, M111.008326
43. Travassos, M. A., Niangaly, A., Bailey, J. A., Ouattara, A., Coulibaly, D., Laurens, M. B., Pablo, J., Jasinskas, A., Nakajima-Sasaki, R., Berry, A. A., Takala-Harrison, S., Kouriba, B., Rowe, J. A., Lyke, K. E., Doumbo, O. K., Thera, M. A., Felgner, P. L., and Plowe, C. V (2013) Seroreactivity to Plasmodium falciparum erythrocyte membrane protein 1 intracellular domain in malaria-exposed children and adults. J. Infect. Dis. 208, 1514-1519
44. Bailey, J. A., Pablo, J., Niangaly, A., Travassos, M. A., Ouattara, A., Coulibaly, D., Laurens, M. B., Takala-Harrison, S. L., Lyke, K. E., Skinner, J., Berry, A. A., Jasinskas, A., Nakajima-Sasaki, R., Kouriba, B., Thera, M. A., Felgner, P. L., Doumbo, O. K., and Plowe, C. V. (2015) Seroreactivity to a large panel of field-derived Plasmodium falciparum Apical Membrane Antigen 1 and Merozoite Surface Protein 1 variants reflects seasonal and lifetime acquired responses to malaria. Am. J. Trop. Med. Hyg. 92, 9-12